TCR2 Therapeutics Inc. EBITDA 2019-2023 | TCRR
TCR2 Therapeutics Inc. Annual EBITDA (Millions of US $) |
|
---|---|
2022 | $-150 |
2021 | $-97 |
2020 | $-67 |
2019 | $-51 |
2018 | $-26 |
2017 | $-13 |
2016 | $-10 |
TCR2 Therapeutics Inc. Quarterly EBITDA (Millions of US $) |
|
---|---|
2023-03-31 | $-41 |
2022-12-31 | $-61 |
2022-09-30 | $-30 |
2022-06-30 | $-31 |
2022-03-31 | $-28 |
2021-12-31 | $-27 |
2021-09-30 | $-25 |
2021-06-30 | $-24 |
2021-03-31 | $-21 |
2020-12-31 | $-18 |
2020-09-30 | $-17 |
2020-06-30 | $-16 |
2020-03-31 | $-16 |
2019-12-31 | $-13 |
2019-09-30 | $-15 |
2019-06-30 | $-12 |
2019-03-31 | $-11 |
2018-12-31 | $-8 |
2018-09-30 | $-7 |
2018-06-30 | $-7 |
2018-03-31 | $-4 |